Press Releases
Financial Summary:
- Net sales were
$44.3 million in the quarter, an increase of$9.2 million , or 26.0%, compared to third quarter 2013 net sales of$35.2 million . The increase was primarily driven by total law enforcement weapon handle sales which increased$6.9 million in the third quarter compared to third quarter of the prior year. International sales were$6.7 million in the quarter an increase of$3.0 million compared to the prior year third quarter.
- TASER Weapons segment revenues grew
$8.4 million year-over-year, or 26.5%, to$40.0 million in the third quarter of 2014.
- EVIDENCE.com & Video segment revenues increased by
$0.8 million , or 21.5%, to$4.3 million in the third quarter of 2014 in comparison to the prior year third quarter. AXON cameras and EVIDENCE.com bookings of$15.3 million , increased$9.5 million , over third quarter 2013 bookings of$5.8 million .
- Gross margin in the third quarter of 2014 was 64.7%, compared to 62.8% in the same period last year. The improvement in gross margin in the third quarter of 2014 was driven by the 26.0% increase in net sales which resulted in better leverage of manufacturing overhead expenses and higher average selling prices.
- Sales, general and administrative (SG&A) expenses of
$12.4 million in the third quarter of 2014 decreased$0.4 million , from$12.8 million in the third quarter of 2013. As a percentage of revenue, SG&A decreased to 28.1% in the third quarter of 2014 compared to 36.3% in the prior year third quarter. Compared to the prior year, personnel expenses increased$1.2 million as the Company has increased customer-facing positions as well as some administrative functions. Expenses also increased in relation to TASER-hosted Technology Summits which take place to promote law enforcement awareness about recent developments in cloud technology. Increases were also seen in travel expense as the Company works to grow its international presence. These increases were partially offset by lower liability insurance rates as well as lower expenses related to the defense of product and commercial litigation. The Company expects to see increased SG&A in the fourth quarter due to the timing of theInternational Association of Chiefs of Police conference. The Company also expects higher SG&A expenses for the fourth quarter 2014 and into 2015 as the Company continues to invest and grow the infrastructure necessary to achieve its initiatives of increasing revenues internationally and in the EVIDENCE.com & Video segment.
- Research and development (R&D) expenses of
$3.8 million for the third quarter of 2014 increased$1.3 million when compared to the third quarter of 2013 driven by additional personnel expense related to EVIDENCE.com & Video segment product development initiatives. The Company continues to expect increased expenses in R&D in the fourth quarter of 2014 and into 2015 as it adds new functionality and new capabilities to the EVIDENCE.com platform.
- Income from operations increased
$5.6 million , or 81.8%, to$12.5 million in the third quarter of 2014 compared to$6.9 million in the third quarter of 2013.
- Adjusted EBITDA was
$15.1 million for the third quarter of 2014, an increase from$9.0 million in the third quarter of 2013.
- Net income for the third quarter of 2014 was
$7.6 million , or$0.14 per diluted share, compared to$5.1 million , or$0.10 per diluted share in the third quarter of 2013.
- In the third quarter of 2014, the Company generated
$16.7 million in cash from operating activities. Cash, cash equivalents and investments were$74.0 million at the end of the third quarter of 2014, up from$63.4 million atDecember 31, 2013 . Included in these balances were$6.4 million and$12.0 million in long-term investments as ofSeptember 30, 2014 andDecember 31, 2013 , respectively.
- The Company completed
$2.9 million of stock repurchases during the quarter, purchasing approximately 0.2 million shares for an average cost of$11.94 per share. During the first nine months of 2014, the Company completed$22.4 million of stock repurchases, purchasing approximately 1.7 million shares for an average cost of$12.99 per share. There is approximately$7.6 million remaining on the current stock repurchase authorization. Repurchases may be made from time to time on the open market.
"We continue to see positive breakthroughs in the adoption of law enforcement cloud technology as evidenced by this quarter's EVIDENCE.com and AXON bookings of
"In addition to increased investments in sales and marketing initiatives related to the international market and EVIDENCE.com, we intend to continue to invest in R&D initiatives related to adding new features and enhanced capabilities, such as the recently announced AXON Signal wireless activation, for existing video and weapons products," Smith continued. "We remain focused on solidifying our leading position in this market going into the New Year. Our investments in R&D and sales and marketing, combined with TASER's market-leading products and excellent customer service, should drive long-term value for all our stakeholders," concluded Smith.
Other Significant Events:
- The Company announced a number of significant orders for its X26P and X2 Smart Weapons during the third quarter, including:
Arlington Police Department (TX)Atlanta Police Department (GA)Bryan Police Department (TX)Central Intelligence Agency Charlotte County Sheriff's Office (FL)Cleveland Police Department (OH)Cobb County Police Department (GA)Connecticut Police Academy (CT)Dallas Police Department (TX)Downey Police Department (CA)Dubuque County Sheriff's Department (LA)Florida Department of Law Enforcement (FL)Guilford County Sheriff's Office (NC)Harris County Constable Precinct 5 (TX)Houston Police Department (TX)Jefferson Parish Sheriff's Office (LA)Kansas City Police Department (MO)Lakeland Police Department (FL)Las Vegas Metro Police Department (NV)Long Beach Police Department (CA)Lynchburg Police Department (VA)Maryland Transportation Authority Police (MD)Maui Police Department (HI)New Braunfels Police Department (TX)New Haven Police Department (CT)North Carolina Highway Patrol (NC)- Panama
Border Patrol Philadelphia Police Department (PA)Pleasanton Police Department (CA)Polk County Sheriff's Office (FL)Randolph Police Department (MA)Redlands Police Department (CA)Rock Hill Police Department (SC)Sandy Springs Police Department (GA)South Carolina Highway Patrol (SC)Suffolk County Police Department (NY)US Bureau of Alcohol, Tobacco, Firearms and Explosives - US Fish and Wildlife Bear River Migratory Bird Refuge (UT)
- US Marshal's
Service Training Academy Waco Police Department (TX)Winnipeg Police Service (Canada )
- The Company continued to see new agencies adopt, and other agencies expand, their deployments of the AXON body-worn cameras and/or EVIDENCE.com management service during the third quarter. AXON and/or EVIDENCE.com significant orders included:
Anaheim Police Department (CA)Birmingham Police Department (AL), add-on orderBurlington Police Department (VT), add-on orderColumbus Police Department (MS)Cullman County Sheriff's Office (AL)Daytona Beach Police Department (FL)Droo Tactical Trading LLC (Abu Dhabi )Flagstaff Police Department (AZ)Fresno Police Department (CA), add-on orderFullerton Police Department (CA)Hanford Police Department (CA)Hayward Police Department (CA)Johnson County Sheriff's Office (KS)Knox County Sheriff's Office (TN)Madison County Sheriff's Department (AL)Meridian Police Department (ID)Muskogee Police Department (OK)Salt Lake City Police Department (UT), add-on orderTopeka Police Department (KS)Upland Police Department (CA)Winston-Salem Police Department (NC), add-on order
- The Company will take questions relating to the third quarter results via social media. TASER management will entertain questions during the call asked via Twitter, in addition to questions from those logged into the webcast. Individuals may submit questions via Twitter using hashtag #TASR_Earnings to the @TASER_IR handle. TASER management regrets that due to time considerations, not all questions may be answered during the call. For those individuals who do not have access to Twitter, all tweets and related content are streamed directly to http://investor.taser.com.
- The Company plans to update and post its investor relations presentation to http://investor.taser.com within the next two weeks with the third quarter results. Archived presentations from previous quarters may also be found on the website.
The Company will host its third quarter 2014 earnings conference call on
Non-GAAP Measures
To supplement the Company's financial results presented in accordance with GAAP, we are presenting the non-GAAP financial measures of EBITDA and Adjusted EBITDA. Our management uses these non-GAAP financial measures in evaluating the Company's performance in comparison to prior periods and as a measure of liquidity. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning and forecasting our future periods. A reconciliation of GAAP to the non-GAAP financial measures is presented at the end of the release.
EBITDA is defined as consolidated net income before interest expense, income taxes and depreciation and amortization. Adjusted EBITDA as presented herein is defined as EBITDA before certain other items, including: stock-based compensation; (gain) loss on write-down/disposal of property, equipment and intangibles, net; provision for obsolete and excess inventory; litigation judgment expense; loss on impairment; and interest income and other (income) expense.
Caution on Use of Non-GAAP Measures
Although these non-GAAP financial measures are not consistent with GAAP, management believes investors will benefit by referring to these non-GAAP financial measures when assessing the Company's operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:
- these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company's GAAP financial measures;
- these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company's GAAP financial measures;
- these non-GAAP financial measures should not be considered to be superior to the Company's GAAP financial measures; and
- these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this earnings release were prepared under a comprehensive set of rules or principles.
Further, these non-GAAP financial measures may be unique to the Company, as they may be different from non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company's results to the results of other companies.
A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure or measures appears within this press release.
About
TASER International makes communities safer with innovative public safety technologies. Founded in 1993, TASER first transformed law enforcement with its electrical weapons. TASER continues to define smarter policing with its growing suite of technology solutions, including AXON body-worn video cameras and EVIDENCE.com, a secure digital evidence management platform. More than 132,000 lives and countless dollars have been saved with TASER's products and services.
Learn more at www.TASER.com and www.EVIDENCE.com or by calling (800) 978-2737.
TASER® and AXON® are registered trademarks of
Note to Investors
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding our expectations, beliefs, intentions or strategies regarding the future; that we expect elevated SG&A and R&D spending in the fourth quarter and into 2015; and that we intend to drive top-line growth internationally and in our EVIDENCE.com & Video business and long-term value by increasing sales activities. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding
These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include, but are not limited to: the impact of recently issued and adopted accounting standards and guidance; the gross margins in the EVlDENCE.com & Video Segment will be lower in the near term; that increased marketing expenditure will lead to sales growth; our anticipation that government contracts will be completed; that fixed costs in our EVIDENCE.com & Video segment will remain stable and result in a lower cost of services delivered as a percentage of revenue; that R&D and SG&A expenses will continue to increase; our litigation strategy and the outcome of pending litigation against us; the sufficiency of our valuation reserves, including warranty, accounts receivable, deferred taxes and inventory reserves; our projected effective tax rate for 2014; the sufficiency of our capital resources and the availability of financing to the Company and our strategy with respect to hedging activities. We caution that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward looking statements herein. Such factors include, but are not limited to: market acceptance of our products; our dependence on sales of our TASER X26, X26P and X2 CEWs; the acceptance of our EVIDENCE.com software model; our ability to design, introduce and sell new products; delays in development schedules; rapid technological change and competition; product defects; breach of our security measures resulting in unauthorized access to customer data; outages and disruptions relating to our EVIDENCE.com service; budgetary and political constraints of prospects and customers; our exposure to cancellations of government contracts due to appropriation clauses; the length of our sales cycle and our ability to realize benefits from our marketing and selling efforts; the long-term revenue recognition cycle for our SaaS EVIDENCE.com product; regulatory and political challenges presented by international markets; litigation risks resulting from alleged product-related injuries and media publicity concerning allegations of deaths occurring after use of the TASER device and the negative impact this publicity could have on sales; the outcome of pending or future litigation; our ability to protect our intellectual property; intellectual property infringement claims and relating litigation costs; competition in foreign countries relating to foreign patents; our successful identification of existing intellectual property rights that might infringe on our developments; risks of governmental regulations, including regulations of our products by the
Please visit http://investor.taser.com, http://blog.taser.com, www.twitter.com/taser_ir, www.twitter.com/officialtaser and https://www.facebook.com/TASERInternational where TASER discloses information from time to time about the company, its financial information, and its business.
For investor relations information please contact
Condensed Consolidated Statements of Operations | ||||||||||
(Unaudited) | ||||||||||
Amounts in thousands, except per share data | ||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||
2014 | 2013 | 2014 | 2013 | |||||||
Net sales | $ | 44,349 | $ | 35,197 | $ | 117,709 | $ | 97,806 | ||
Cost of products sold and services delivered | 15,636 | 13,101 | 43,574 | 37,517 | ||||||
Gross margin | 28,713 | 22,096 | 74,135 | 60,289 | ||||||
Sales, general and administrative expenses | 12,441 | 12,776 | 39,734 | 34,898 | ||||||
Research and development expenses | 3,759 | 2,439 | 10,820 | 6,444 | ||||||
Income from operations | 12,513 | 6,881 | 23,581 | 18,947 | ||||||
Interest and other income (expense), net | (160 | ) | 35 | (88 | ) | 31 | ||||
Income before provision for income taxes | 12,353 | 6,916 | 23,493 | 18,978 | ||||||
Provision for income taxes | 4,795 | 1,802 | 8,661 | 6,109 | ||||||
Net income | $ | 7,558 | $ | 5,114 | $ | 14,832 | $ | 12,869 | ||
Income per common and common equivalent shares | ||||||||||
Basic | $ | 0.14 | $ | 0.10 | $ | 0.28 | $ | 0.25 | ||
Diluted | $ | 0.14 | $ | 0.10 | $ | 0.27 | $ | 0.24 | ||
Weighted average number of common and common equivalent shares outstanding | ||||||||||
Basic | 52,475 | 51,342 | 53,013 | 51,727 | ||||||
Diluted | 53,821 | 53,321 | 54,550 | 53,644 | ||||||
Segment Reporting |
(Unaudited) |
Dollars in thousands |
Three Months Ended |
Three Months Ended |
|||||||||||||||||
TASER Weapons | EVIDENCE.com & Video |
Total | TASER Weapons | EVIDENCE.com & Video |
Total | |||||||||||||
Product sales | $ | 40,010 | $ | 3,181 | $ | 43,191 | $ | 31,627 | $ | 3,103 | $ | 34,730 | ||||||
Service revenue | - | 1,158 | 1,158 | - | 467 | 467 | ||||||||||||
Net sales | 40,010 | 4,339 | 44,349 | 31,627 | 3,570 | 35,197 | ||||||||||||
Cost of products sold | 12,443 | 2,695 | 15,138 | 10,908 | 1,896 | 12,804 | ||||||||||||
Cost of services delivered | - | 498 | 498 | - | 297 | 297 | ||||||||||||
Gross margin | 27,567 | 1,146 | 28,713 | 20,719 | 1,377 | 22,096 | ||||||||||||
Sales, general and administrative | 10,028 | 2,413 | 12,441 | 11,131 | 1,645 | 12,776 | ||||||||||||
Research and development | 1,050 | 2,709 | 3,759 | 1,160 | 1,279 | 2,439 | ||||||||||||
Income (loss) from operations | $ | 16,489 | $ | (3,976 | ) | $ | 12,513 | $ | 8,428 | $ | (1,547 | ) | $ | 6,881 | ||||
Operating margin % | 41 | % | -92 | % | 28 | % | 27 | % | -43 | % | 20 | % | ||||||
Nine Months Ended |
Nine Months Ended |
|||||||||||||||||
TASER Weapons | EVIDENCE.com & Video |
Total | TASER Weapons | EVIDENCE.com & Video |
Total | |||||||||||||
Product sales | $ | 105,160 | $ | 9,812 | $ | 114,972 | $ | 89,902 | $ | 6,853 | $ | 96,755 | ||||||
Service revenue | - | 2,737 | 2,737 | - | 1,051 | 1,051 | ||||||||||||
Net sales | 105,160 | 12,549 | 117,709 | 89,902 | 7,904 | 97,806 | ||||||||||||
Cost of products sold | 34,024 | 8,111 | 42,135 | 31,535 | 4,440 | 35,975 | ||||||||||||
Cost of services delivered | - | 1,439 | 1,439 | - | 1,542 | 1,542 | ||||||||||||
Gross margin | 71,136 | 2,999 | 74,135 | 58,367 | 1,922 | 60,289 | ||||||||||||
Sales, general and administrative | 32,218 | 7,516 | 39,734 | 30,622 | 4,276 | 34,898 | ||||||||||||
Research and development | 2,660 | 8,160 | 10,820 | 3,126 | 3,318 | 6,444 | ||||||||||||
Income (loss) from operations | $ | 36,258 | $ | (12,677 | ) | $ | 23,581 | $ | 24,619 | $ | (5,672 | ) | $ | 18,947 | ||||
Operating margin % | 34 | % | -101 | % | 20 | % | 27 | % | -72 | % | 19 | % | ||||||
AXON flex, AXON body and EVIDENCE.com Bookings by Quarter | ||||||||||||||
(Unaudited) | ||||||||||||||
Dollars in thousands | ||||||||||||||
For the Quarter Ended, | ||||||||||||||
2014 |
2014 |
2014 |
2013 |
2013 |
||||||||||
Bookings | $ | 15,267 | $ | 11,346 | $ | 5,919 | $ | 5,206 | $ | 5,847 | ||||
AXON flex, AXON body and EVIDENCE.com bookings represent a statistical measure defined as the sales price of orders placed in the relevant time period. Bookings are an indication of the activity the Company is seeing relative to AXON flex, AXON body and EVIDENCE.com. We consider bookings to be a statistical measure defined as the sales price of orders (not invoiced sales) placed in the relevant fiscal period, regardless of when the products or services ultimately will be provided. Some bookings will be invoiced in subsequent years.
Due to municipal government funding rules, certain of the future year amounts included in bookings are subject to budget appropriation or other contract cancellation clauses. Although TASER has entered into contracts for the delivery of products and services in the future and anticipates the contracts will be completed, if agencies do not appropriate money in future year budgets or invoke a cancellation clause, revenue associated with these bookings will not ultimately be recognized, resulting in a future reduction to bookings.
For more information relative to our revenue recognition policies, please reference our
Unit Sales Statistics |
(Unaudited) |
Units and percentages in whole numbers |
Three Months Ended |
Nine Months Ended |
|||||||||||||||||
2014 | 2013 | Unit Change | Percent Change | 2014 | 2013 | Unit Change | Percent Change | |||||||||||
TASER X26 | 2,775 | 7,195 | (4,420 | ) | (61.4 | )% | 14,220 | 24,296 | (10,076 | ) | (41.5 | )% | ||||||
TASER X2 | 10,694 | 8,469 | 2,225 | 26.3 | 18,673 | 20,431 | (1,758 | ) | (8.6 | ) | ||||||||
TASER X26P | 15,466 | 7,327 | 8,139 | 111.1 | 36,673 | 17,663 | 19,010 | 107.6 | ||||||||||
TASER C2 | 1,462 | 1,544 | (82 | ) | (5.3 | ) | 5,003 | 5,869 | (866 | ) | (14.8 | ) | ||||||
M26 | 499 | 502 | (3 | ) | (0.6 | ) | 1,377 | 1,638 | (261 | ) | (15.9 | ) | ||||||
Single Cartridges | 403,613 | 375,363 | 28,250 | 7.5 | 1,142,663 | 1,153,825 | (11,162 | ) | (1.0 | ) | ||||||||
StrikeLight | 350 | 1,322 | (972 | ) | (73.5 | ) | 2,767 | 1,322 | 1,445 | 109.3 | ||||||||
TASER XREP | - | - | - | * | 3,770 | - | 3,770 | * | ||||||||||
AXON flex | 2,577 | 1,217 | 1,360 | 111.8 | 6,176 | 3,580 | 2,596 | 72.5 | ||||||||||
AXON body | 3,224 | 774 | 2,450 | 316.5 | 8,651 | 774 | 7,877 | * | ||||||||||
TASER Cam | 1,967 | 3,343 | (1,376 | ) | (41.2 | ) | 7,174 | 8,349 | (1,175 | ) | (14.1 | ) | ||||||
* Not meaningful | ||||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures |
(Unaudited) |
Dollars in thousands |
For the Three Months Ended | For the Nine Months Ended | ||||||||||||
2014 |
2013 |
2014 |
2013 |
||||||||||
Net income | $ | 7,558 | $ | 5,114 | $ | 14,832 | $ | 12,869 | |||||
Depreciation and amortization | 1,101 | 1,088 | 3,368 | 4,036 | |||||||||
Interest expense | 1 | 2 | 3 | 8 | |||||||||
Provision for income taxes | 4,795 | 1,802 | 8,661 | 6,109 | |||||||||
EBITDA | $ | 13,455 | $ | 8,006 | $ | 26,864 | $ | 23,022 | |||||
Adjustments: | |||||||||||||
Stock-based compensation expense | 1,437 | 962 | 4,121 | 2,906 | |||||||||
(Gain) loss on write-down/disposal of property, equipment and intangibles, net | 85 | 2 | 228 | 84 | |||||||||
Provision for excess and obsolete inventory | 5 | 110 | 20 | 279 | |||||||||
Other expense (income) | 159 | (37 | ) | 85 | (39 | ) | |||||||
Adjusted EBITDA | $ | 15,141 | $ | 9,043 | $ | 31,318 | $ | 26,252 | |||||
Adjusted EBITDA as a percentage of net sales | 34.1 | % | 25.7 | % | 26.6 | % | 26.8 | % | |||||
Composition of stock-based compensation: | |||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||
2014 |
2013 |
2014 |
2013 |
||||||||||
Cost of products sold | $ | 61 | $ | 50 | $ | 149 | $ | 134 | |||||
Sales, general and administrative expenses | 940 | 734 | 2,598 | 2,293 | |||||||||
Research and development expenses | 436 | 178 | 1,374 | 479 | |||||||||
$ | 1,437 | $ | 962 | $ | 4,121 | $ | 2,906 | ||||||
Condensed Consolidated Balance Sheets | ||||||||
Dollars in thousands | ||||||||
2014 |
2013 |
|||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 38,615 | $ | 42,271 | ||||
Short-term investments | 28,983 | 9,101 | ||||||
Accounts and notes receivable, net | 27,099 | 22,488 | ||||||
Inventory, net | 16,128 | 11,109 | ||||||
Prepaid expenses and other current assets | 5,210 | 5,397 | ||||||
Deferred income tax assets, net | 7,164 | 7,101 | ||||||
Total current assets | 123,199 | 97,467 | ||||||
Property and equipment, net | 17,848 | 19,043 | ||||||
Deferred income tax assets, net | 9,603 | 13,679 | ||||||
Intangible assets, net | 3,107 | 3,317 | ||||||
Goodwill | 2,206 | 2,235 | ||||||
Long-term investments | 6,411 | 12,023 | ||||||
Other assets | 1,766 | 618 | ||||||
Total assets | $ | 164,140 | $ | 148,382 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 6,483 | $ | 6,221 | ||||
Accrued liabilities | 6,853 | 8,840 | ||||||
Current portion of deferred revenue | 10,033 | 6,878 | ||||||
Customer deposits | 369 | 1,154 | ||||||
Current portion of capital lease payable | 38 | 36 | ||||||
Total current liabilities | 23,776 | 23,129 | ||||||
Deferred revenue, net of current portion | 19,966 | 13,341 | ||||||
Liability for unrecognized tax benefits | 1,409 | 3,122 | ||||||
Other long-term liabilities | 908 | 376 | ||||||
Long-term portion of capital lease payable | 39 | 67 | ||||||
Total liabilities | 46,098 | 40,035 | ||||||
Stockholders' Equity: | ||||||||
Preferred stock | - | - | ||||||
Common stock | 1 | 1 | ||||||
Additional paid-in capital | 156,729 | 139,424 | ||||||
Treasury stock | (114,645 | ) | (92,203 | ) | ||||
Retained earnings | 75,959 | 61,127 | ||||||
Accumulated other comprehensive loss | (2 | ) | (2 | ) | ||||
Total stockholders' equity | 118,042 | 108,347 | ||||||
Total liabilities and stockholders' equity | $ | 164,140 | $ | 148,382 | ||||
- | - |
Selected Cash Flow Information | ||||||||||||
(Unaudited) | ||||||||||||
Dollars in thousands | ||||||||||||
For the Three Months Ended | For the Nine Months Ended | |||||||||||
2014 |
2013 |
2014 |
2013 |
|||||||||
Net income | $ | 7,558 | $ | 5,114 | $ | 14,832 | $ | 12,869 | ||||
Depreciation and amortization | 1,101 | 1,088 | 3,368 | 4,036 | ||||||||
Stock-based compensation expense | 1,437 | 962 | 4,121 | 2,906 | ||||||||
Net cash provided by operating activities | 16,676 | 10,864 | 22,638 | 23,087 | ||||||||
Net cash used in investing activities | (2,683 | ) | (1,232 | ) | (17,126 | ) | (13,236 | ) | ||||
Net cash provided by (used in) financing activities | (1,412 | ) | 6,302 | (9,284 | ) | (10,969 | ) | |||||
Cash and cash equivalents, end of period | 38,615 | 35,006 | 38,615 | 35,006 | ||||||||
CONTACT:
Chief Financial Officer
(480) 905-2000
Source:
News Provided by Acquire Media